#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous lupus erythematosus Bladder cancer Acute graft versus host disease Selective polysaccharide antibody deficiency Anti-neutrophil cytoplasmic antibody positive vasculitis ROHHAD syndrome Brain abscess Red blood cell abnormality Peritoneal mesothelioma malignant Granulomatosis with polyangiitis Cystic fibrosis gastrointestinal disease White matter lesion Lymphoma Infantile apnoea Rheumatoid arthritis More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Treatment Hepatic angiosarcoma – Trials in Disease Leukoencephalopathy – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Systemic sclerosis pulmonary – Treatment Usher’s syndrome – Life with Disease Inclusion body myositis – Treatment Hairy cell leukaemia Retinitis pigmentosa – Trials in Disease Myxofibrosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ro7790121 Aripiprazole Calcium Elafibranor Letrozole GXV813 Inaxaplin Caffeine Citrate Favezelimab Ketotifen Hydrogen Fumarate Esmolol Hydrochloride Theophylline Allo-647 Baricitinib ALLO-QUADCAR01-T ULTEVURSEN Aldesleukin ARGININE GLUTAMATE GSKVX000000034798 Estradiol More therapies…

    Learn about Your Condition

    Lung disorder Catatonia Syphilis Lung neoplasm malignant Pigmentary glaucoma Cardiogenic shock Cerebral palsy Inclusion body myositis Cushing's syndrome Genitourinary tract neoplasm Dengue fever Corneal graft failure Lichen planopilaris Atrial fibrillation Osteopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Airway Changes in Patients with Residual Neuromuscular Blockade Using Sugammadex and Rocuronium Bromide

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    Hungary

  • Study on the Effects of CD34+ Cells for Patients with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE
    Portugal

  • Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
    France Italy Latvia Poland Slovakia Spain

  • Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    • Triptorelin
    Italy

  • Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biotinidase deficiency
    Investigated Drugs:
    • Biotin
    Spain

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9
Previous Page
1 … 804 805 806 807 808 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!